Alternatives to Talc-Based Cosmetics

Alternatives to Talc-Based Cosmetics

This podcast episode explores the role of talc in cosmetics like body powders and eyeshadows, regulations around talc in cosmetics, alternatives to talc-based products and how consumers can better understand the “asbestos-free” and “natural” labels many of these products carry. Our host is Danielle DiPietro, financial advocate and board-certified patient advocate at The Mesothelioma Center at Asbestos.com [http://Asbestos.com], and our guest is Whitney Di Bona, an attorney and consumer safety advocate at Drugwatch.com [http://Drugwatch.com].

Using AI in Cancer Care

In this podcast episode from The Mesothelioma Center, host Walter Pacheco interviews Dr. Estelamari Rodriguez, a thoracic medical oncologist at the Sylvester Comprehensive Cancer Center, about the growing use of AI in cancer care. Dr. Rodriguez discusses how patients are increasingly using AI tools like ChatGPT to research their mesothelioma diagnosis, generate structured questions for doctor visits, and understand treatment options. While she sees AI as a valuable educational tool that empowers patients and improves medical literacy, she emphasizes important limitations, particularly for rare diseases like mesothelioma where published data is limited. The conversation covers the digital divide among different age groups, the importance of maintaining doctor-patient relationships despite AI use, and the need for patients to verify AI-generated information with medical experts. Dr. Rodriguez also explores the future potential of AI in research, including better tumor modeling and faster clinical trial development through international data collaboration. Throughout the discussion, she stresses that while AI can enhance patient education and communication, it cannot replace the expertise of experienced medical teams familiar with mesothelioma treatment and clinical trial opportunities.

Understanding Asbestos Exposure and Emergency Restoration

Managing editor at The Mesothelioma Center at Asbestos.com [http://Asbestos.com], Walter Pacheco, interviews Chief Operating Officer and Principal Project Consultant for ELEMENT Building Sciences, Derrick J. Hall. The podcast dives into the role of restoration in asbestos exposure, Hall’s experience encountering asbestos in Puerto Rico in the aftermath of Hurricane Maria, increasing asbestos awareness and training, and his work with the Restoration Industry Association, among other topics related to asbestos exposure.

The Push for an Asbestos Ban at a Critical Moment

Medical Outreach Director Missy Miller of The Mesothelioma Center interviews Linda Reinstein, BCPA, president and co-founder of the Asbestos Disease Awareness Organization. Reinstein launched ADAO after doctors diagnosed her husband, Alan Reinstein, with mesothelioma. She channeled that personal tragedy into global advocacy through storytelling, an annual Global Asbestos Awareness Week, and a curated book of over 200 patient and family stories. Reinstein also champions the Alan Reinstein Ban Asbestos Now Act. In this podcast, Reinstein discusses how the ARBAN bill seeks to ban all eight asbestos fibers and raises transparency concerns about the White House East Wing demolition, having filed Freedom of Information Act requests to verify whether administration officials followed proper asbestos inspection, abatement and disposal regulations in that project.

The Impact of Federal Funding on Cancer Research

Chief Medical Officer at The Mesothelioma Center, Dr. Catherine Perrault, and Director of Thoracic Oncology at the University of Hawaii Cancer Center, Dr. Michele Carbone, discuss the impact of federal funding on cancer research, specifically its progressive decline over the last 25 years. Together, they explain how the amount of money allocated in grants, which leads to treatment [https://www.asbestos.com/treatment/] innovations, has not kept pace with inflation and the rising cost of newer technology. This episode particularly explores how the decrease in funding affects all cancers, but rare cancers like mesothelioma [https://www.asbestos.com/mesothelioma/] are disproportionately impacted because study sections inevitably prioritize more common malignancies like lung, breast and prostate cancer. Dr. Carbone stresses that research isn’t solely funded by the federal government, and that it needs more support from pharma, donations and the American people.